KTTA
HealthcarePasithea Therapeutics Corp.
Prev Close
$0.83
Open
$0.79
High
$0.83
Low
$0.79
Volume
42.9K
Market Cap
$6.0M
P/E
—
Div Yield
—
Over the past 12 months, insider activity at Pasithea Therapeutics Corp. (KTTA) has been exclusively buying, with 3 insider purchases totaling $150.0K and 0 insider sales totaling $0.00. The most recent insider transaction was by Dumesnil Simon (Director), who purchased $25.0K worth of shares on Nov 28, 2025. Pasithea Therapeutics Corp. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $6.0M.
KTTA Insider Trading Activity
KTTA Insider Buying Activity
The following table shows recent insider purchases of Pasithea Therapeutics Corp. (KTTA) stock reported via SEC Form 4 filings.
KTTA Insider Selling Activity
The following table shows recent insider sales of Pasithea Therapeutics Corp. (KTTA) stock reported via SEC Form 4 filings.
No insider selling activity found for KTTA in the last 12 months.